– GEN’s Editor-in-Chief John Sterling interviews Dr. Peter Navarro from the Paul Merage School of Business at the University of California, Irvine, about the pitfalls of doing biotech R&D and manufacturing in China.

Previous articleConsortium Reports Analysis of Phase II HapMap
Next articleCobra to Continue Backing Advaxis’ Cervical Cancer Vaccine Clinical Trials